National Center for Tumor Diseases (NCT) Heidelberg
Christoph E. Heilig is a Clinical and Research Fellow in Translational Medical Oncology at the National Center for Tumor Diseases (NCT) Heidelberg since August 2017, also serving as a Fellow of NCT-HSO. Prior experience includes roles as a Clinical and Research Fellow and Resident at the Sarcoma Center, Heidelberg University from 2014 to July 2018, and as a Specialist in Internal Medicine, Hematology, and Oncology at the University of Heidelberg from January 2010 to July 2018. Previous positions at the DKFZ German Cancer Research Center from June 2006 to March 2017 included roles as a Postdoc and MD student in the Clinical Cooperation Unit Molecular Hematology/Oncology. Christoph E. Heilig earned a Dr. med. degree from Heidelberg University and the DKFZ in 2010, following the completion of a Doctor of Medicine (M.D.) in Medicine from Heidelberg University in 2009.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.